# NCT03742297 (NCT03742297)

> Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03742297
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: PETHEMA Foundation
- Conditions: Newly Diagnosed Multiple Myeloma
- Interventions: Lenalidomide.; Carfilzomib; Bortezomib; Daratumumab; Dexamethasone; Prednisone; Melphalan
- Enrollment: 462
- Primary outcome: Efficacy in terms of numbers of compleat responses

## Commentary we found

- X threads: 19
- YouTube: 7
- Podcasts: 6

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=nct03742297

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03742297", "email": "<work email>"}; the inbox owner confirms by the emailed link.